Eli Lilly and Company (LLY)

374.76
+4.43(+1.20%)
After Hours
374.68
-0.08(-0.02%)
- Real-time Data
  • Volume:
    1,923,195
  • Day's Range:
    365.00 - 375.04
  • 52 wk Range:
    231.87 - 375.19

LLY Overview

Prev. Close
370.33
Day's Range
365-375.04
Revenue
28.01B
Open
366.08
52 wk Range
231.87-375.19
EPS
6.68
Volume
1,923,195
Market Cap
356.09B
Dividend (Yield)
3.92
(1.05%)
Average Volume (3m)
3,041,631
P/E Ratio
54.91
Beta
0.358
1-Year Change
51.19%
Shares Outstanding
950,177,900
Next Earnings Date
Feb 01, 2023
What is your sentiment on Eli Lilly?
or
Market is currently closed. Voting is open during market hours.

Eli Lilly and Company News

Eli Lilly and Company Analysis

Eli Lilly and Company Company Profile

Eli Lilly and Company Company Profile

Employees
35000

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin’s lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Read More

Analyst Price Target

Average371.23 (-0.94% Downside)
High436
Low202
Price374.76
No. of Analysts26
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy